期刊
JOURNAL OF CLINICAL NEUROSCIENCE
卷 17, 期 9, 页码 1165-1168出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.jocn.2010.01.042
关键词
Catechins; (-)-Epigallocatechin-3-gallate; Green tea; Inducible nitric oxide synthase; MPTP; Parkinson's disease
资金
- Seoul National University Bundang Hospital [02-2005-027, 02-2006-014]
The aim of this study was to investigate the involvement of inducible nitric oxide synthase (iNOS) in the action of (-)-epigallocatechin-3-gallate (EGCG), a potential neuroprotective agent against Parkinson's disease (PD), and to test for toxicity resulting from high doses of EGCG. EGCG was administered to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mice at two different doses (10 mg/kg and 50 mg/kg). EGCG treatment reduced the neuronal death rate to less than 50%. The level of iNOS expression in the MPTP group was 20% higher than that seen in the control group, but in the EGCG groups, iNOS expression was reduced to the level observed in the negative control group. The two doses of EGCG were equally beneficial for cell rescue, and no toxicity was observed with the higher dose. Inhibition of iNOS may be an important mechanism underlying the prevention of MPTP toxicity, and EGCG may potentially be a neuroprotective agent against PD. (C) 2010 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据